Mirum Pharmaceuticals
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $127,785 | $111,585 | $99,414 | $90,377 |
Gross Profit | 104,364 | 88,567 | 76,634 | 69,571 |
EBITDA | 4,186 | -4,000 | -14,731 | -4,247 |
EBIT | -1,870 | -10,052 | -20,787 | -10,302 |
Net Income | -5,861 | -14,677 | -23,790 | -14,235 |
Net Change In Cash | 127,785 | 111,585 | 99,414 | 90,377 |
Free Cash Flow | 11,914 | -2,002 | -5,088 | -6,197 |
Cash | 228,122 | 211,822 | 222,503 | 222,969 |
Basic Shares | 49,726 | 48,889 | 48,338 | 47,783 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $336,888 | $186,374 | $77,062 | $19,138 |
Gross Profit | 255,245 | 139,335 | 64,688 | 17,235 |
EBITDA | -48,972 | -136,490 | -122,411 | -65,386 |
EBIT | -72,601 | -147,319 | -126,092 | -66,361 |
Net Income | -87,942 | -163,415 | -135,665 | -83,988 |
Net Change In Cash | 336,888 | 186,374 | 77,062 | 19,138 |
Cost of Revenue | -3,349 | -10,745 | ||
Free Cash Flow | 9,332 | -91,053 | -120,414 | -151,782 |
Cash | 222,503 | 286,326 | 28,003 | 31,340 |
Basic Shares | 47,523 | 40,885 | 33,839 | 30,321 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | -$0.12 |
2025-03-31 | -$0.30 |
2024-12-31 | -$0.49 |
